₹ 656.30
1.55 (0.24%)
B
Bliss GVS Pharma
₹ 656.30
Bliss GVS Pharma EPS Summary (consolidated)
The latest quarterly EPS of Bliss GVS Pharma as of Q2 Sep 2026 stands at ₹4.92. This is a 4.02% growth quarter on quarter and 90.70% growth same quarter last year. For the FY2026 the EPS of Bliss GVS Pharma stands at ₹12.23. This is a 52.49% growth compared with FY2025.
Bliss GVS Pharma EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

